The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study

Annals of Emergency Medicine

Volumn 45, Issue 4, 2005, Pages 377-384

  Kwiatkowski, Thomas ^a   Libman, Richard ^a   Tilley, Barbara C ^b   Lewandowski, Christopher ^c   Grotta, James C ^d   Lyden, Patrick ^e   Levine, Steven R ^f   Brott, Thomas ^g  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c HENRY FORD HOSPITAL   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; PLACEBO; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; HUMAN; KAPLAN MEIER METHOD; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RANKIN SCALE; STROKE; BRAIN ISCHEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EMERGENCY HEALTH SERVICE; HOSPITALIZATION; MULTICENTER STUDY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK; TIME; TREATMENT OUTCOME;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; EMERGENCY SERVICE, HOSPITAL; HUMANS; ODDS RATIO; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 17844387117     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2004.06.021     Document Type: Article

References (12)

1. The National Institute of Neurologic Disorders and Stroke rtPA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1995 1581 1587
2. J.R. Marler, B.C. Tilley, and M. Lu for the NINDS rtPA Stroke Study Group Early stroke treatment associated with better stroke outcome: the NINDS rtPA Stroke Study Neurology 55 2000 1649 1655
3. H.P. Adams, P.H. Davis, and E.C. Leira Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST) Neurology 53 1999 126 131
4. J. Mann Truths about the NINDS study: setting the record straight West J Med 176 2002 192 194
5. T.G. Kwiatkowski, R.B. Libman, and M. Frankel Effects of tissue plasminogen activator for acute ischemic stroke at one year: National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group N Engl J Med 340 1999 1781 1787
6. P. Lyden, T. Brott, and B. Tilley Improved reliability of the NIH Stroke Scale using video training Stroke 25 1994 2220 2226
7. M. Lefkopoulou, D. Moore, and L. Ryan The analysis of multiple correlated binary outcomes: application to rodent teratology experiments J Am Stat Assoc 84 1989 810 815
8. S.L. Zeger, and K.Y. Liang Longitudinal data analysis for discrete and continuous outcomes Biometrics 42 1986 121 130
9. B.C. Tilley, J. Marler, and N.C. Geller Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke rtPA Trial Stroke 27 1996 2136 2142
10. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group Generalized efficacy of tPA for acute stroke: subgroup analysis of the NINDS tPA Stroke Trial Stroke 28 1997 2119 2125
11. C. Grotta The NINDS stroke study group response J Stroke Cerebrovasc Dis 11 2002 121 124
12. S. Yusuf, J. Wittes, and J. Probstfield Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials JAMA 226 1991 93 98